Morning Breakouts

Latest KFF Health News Stories

Mysterious Residue On Equipment Has Delayed Hundreds Of Surgeries In Colo.

Morning Briefing

Initial testing on the substance — previously described as black flecks on reusable surgical instruments at Rocky Mountain Regional VA Medical Center — came back as inconclusive. Also: Hospital-at-home nurses at Boston’s Mass General Brigham have voted to unionize.

CMS To End Advance-Payment Program For Those Affected By Hack

Morning Briefing

The program, launched in March in the aftermath of the Change Healthcare cyberattack, sent advance payments to providers whose operations were disrupted. CMS also announced a do-over of 2024 quality scores for Medicare Advantage plans.

First Edition: June 18, 2024

Morning Briefing

Today’s early morning highlights from the major news organizations. Note to readers: KFF Health News’ First Edition will not be published tomorrow, June 19, in observance of Juneteenth. Look for it again in your inbox Thursday.

Major US Heat Wave Could Affect You Even More If You Take Certain Meds

Morning Briefing

Diuretics, ACE inhibitors, beta blockers, antidepressants, and stimulants for ADHD are just some of the medications that could cause dehydration, raise your risk of fainting, or other problems. Doctors are advising people to use air conditioning and to drink plenty of water.

Federal Effort To Lower Opioid Overdoses By 40% Failed To Work

Morning Briefing

Stat says the study, which began in 2019 and was aimed at using evidence-based interventions, didn’t actually curb opioid overdose deaths. Separately, the Boston Globe reports on growing overdoses in that city last year, and KCUR reports on an opioid antidote initiative from Kansas prisons.

US Patent Office Takes Aim At Pharma Industry Pricing Strategy

Morning Briefing

The U.S. Patent and Trademark Office is targeting “patent thickets,” a tactic used by companies to delay arrival of competing generic medicines, which typically cost less. Meanwhile, the CEO of Novo Nordisk is set to testify before the Senate about the high cost of Ozempic and Wegovy.

Fauci’s Memoir Reveals Covid Response Details, Highlights His Life In Service

Morning Briefing

Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, writes in his new book that early in the pandemic, he worried that “we were in trouble if citizens were growing distrustful of the government’s approach to COVID.” His memoir hits shelves Tuesday.

Surgeon General Urges Congress To Put Warning Labels On Social Media

Morning Briefing

Dr. Vivek Murthy points to the effects of social media on children and teens, arguing that a warning label would convey “that social media has not been proved safe.” Also in the news: Stanford’s online misinformation research group may shut down; study suggests dads should be screened for postpartum depression; and more.

Longer Looks: Interesting Reads You Might Have Missed

Morning Briefing

Each week, KFF Health News finds longer stories for you to enjoy. This week’s selections include stories on weight loss drugs, diabetes tech, marijuana, space travel, and more.

Federal Judge Blocks Trans Protections In 4 States

Morning Briefing

President Joe Biden’s Title IX rules to protect transgender people from gender discrimination were temporarily blocked by U.S. District Judge Terry Doughty of Louisiana, a nominee of President Donald Trump. The judge said the rules were an “abuse of power.”

Pentagon Ran Effort To Smear Chinese Covid Shots In Philippines: Reuters

Morning Briefing

A Reuters investigation revealed a previously unreported story about a secret U.S. military effort to attack perceived rising Chinese influence in the Philippines during the pandemic. The operation sowed doubt about safety and efficacy of Chinese-made covid shots and also attacked face mask quality and test kits.

Telehealth Execs Charged In Alleged Scheme To Bilk Pharmacies, Insurers

Morning Briefing

Done Global’s founder and head doctor are accused of targeting patients seeking stimulants and “deceptive” advertising, the Justice Department alleges. As a result of the charges, patients in need of ADHD drugs and other stimulants might find those medications hard to come by.